Feifei Qi
Publications by Year
Research Areas
CAR-T cell therapy research, Advancements in Semiconductor Devices and Circuit Design, Integrated Circuits and Semiconductor Failure Analysis, Virus-based gene therapy research, Nanowire Synthesis and Applications
Most-Cited Works
- → Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy(2017)220 cited
- → Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma(2019)163 cited
- → Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia(2020)118 cited
- → The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing(2016)35 cited
- → Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies(2021)26 cited
- → Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma(2019)24 cited
- → Which is better in CD19 CAR-T treatment of r/r B-ALL, CD28 or 4-1BB? A parallel trial under the same manufacturing process.(2018)16 cited
- → The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients(2020)15 cited
- → Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion(2022)12 cited
- → Distribution Measurements of Chimeric Antigen Receptor-Modified T Cells Against CD19(2020)